Showing results (501-510 of 2,000) with videos related to
Sort By:
Pageof 200
Journal of Clinical Lipidology|September 25, 2026
Current challenges in diagnosing homozygous familial hypercholesterolemia: Insights from the historical evolution of diagnostic criteriaDaniel Gaudet, Richard Godin, Robert S Rosenson, et al.Journal of Clinical Lipidology|October 6, 2026
Uncovering dysbetalipoproteinemia in a patient initially diagnosed with familial hypercholesterolemia: The role of whole exome sequencing and longitudinal follow-up in diagnostic precision and careSharon L T Pek, Sanjaya U Dissanayake, Hoe M Chen, et al.Journal of Clinical Lipidology|October 6, 2026
Expanding the LDL-C criterion for suspected homozygous familial hypercholesterolemia to include treated and imputed elevationsG B John Mancini, Frederick J RaalJournal of Clinical Lipidology|October 7, 2026
Safety and tolerability of nonstatin LDL-cholesterol-lowering therapies: A systematic review and pairwise meta-analysis of randomized controlled trialsAndrea Matteucci, Michela Bonanni, Stefania Angela Di Fusco, et al.Journal of Clinical Lipidology|October 7, 2026
Does the evidence support the ACC/AHA multisociety recommendation to measure apoB only after LDL-C and non-HDL-C are at target?Justine Cole, Line Dufresne, Peter P Toth, et al.Journal of Clinical Lipidology|February 5, 2011
Intrinsic enzymes of high-density lipoproteinNgoc-Anh Le, Mary F WalterJournal of Clinical Lipidology|February 5, 2011
Should both HDL-C and LDL-C be targets for lipid therapy? A review of current evidenceB Greg Brown, Xue-Qiao Zhao, Marian C CheungJournal of Clinical Lipidology|February 5, 2011
Pilot study of combined therapy with ω-3 fatty acids and niacin in atherogenic dyslipidemiaWilliam L Isley, John M Miles, William S HarrisJournal of Clinical Lipidology|February 5, 2011
Free oxygen radicals in whole blood correlate strongly with high-sensitivity C-reactive proteinMatthey T Harris, Warren W Davis, Ngoc-Anh Le, et al.Journal of Clinical Lipidology|February 5, 2011
Effects of adding extended-release niacin and colesevelam to statin therapy on lipid levels in subjects with atherosclerotic diseaseAndrew Moore, Binh An P Phan, Catherine Challender, et al.Pageof 200